Published in
Elsevier, EBioMedicine, (46), p. 444-451, 2019
DOI: 10.1016/j.ebiom.2019.07.016
Links
Tools
Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial
Journal article published in 2019 by
Rahim Mohammad Naimi 
,
Mark Hvistendahl,
Nikolaj Nerup,
Rikard Ambrus,
Michael Patrick Achiam,
Lars Bo Svendsen,
Henning Grønbæk,
Holger Jon Møller ,
Hendrik Vilstrup,
Adam Steensberg,
Palle Bekker Jeppesen
,
Mark Hvistendahl,
Nikolaj Nerup,
Rikard Ambrus,
Michael Patrick Achiam,
Lars Bo Svendsen,
Henning Grønbæk,
Holger Jon Møller ,
Hendrik Vilstrup,
Adam Steensberg,
Palle Bekker Jeppesen
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 